Ardalanejaz Ahmad

Assistant Professor

University of Manitoba

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ardalanejaz Ahmad is an Assistant Professor at the University of Manitoba, Canada. His research primarily focuses on urologic cancers, with recent articles exploring the psychological and clinical implications of prostate cancer, including its diagnosis, treatment, and the effects of military service on cancer outcomes. He has also investigated the changes in cancer incidence and the management of urologic cancers during the COVID-19 pandemic.

Articles (10)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Thenappan Chandrasekar

UNITED STATES

View details

Hanan Goldberg

Assistant Professor

SUNY Upstate Medical University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ardalanejaz Ahmad

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Clinical-genomic Characterization Unveils More Aggressive Disease Features in Elderly Prostate Cancer Patients with Low-grade Disease

Can post‐treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer?

Is there an association between a history of military service and cancer diagnosis? Results from a US national-level study of self-reported outcomes

Prostate cancer age-standardised incidence increase between 2006 and 2016 in Gauteng Province, South Africa: A laboratory data-based analysis

Does Time Spent on Active Surveillance Adversely Affect the Pathological and Oncologic Outcomes in Patients Undergoing Delayed Radical Prostatectomy?

Gender-based psychological and physical distress differences in patients diagnosed with non-metastatic renal cell carcinoma

Management of urologic cancers during the pandemic and potential impact of treatment deferrals on outcomes

Predictors of prostate-specific antigen testing in men aged ≥55 years: A cross-sectional study based on patient-reported outcomes

Prostate cancer age-standardised incidence increase between 2006 and 2016 in Gauteng Province, South Africa: A laboratory data-based analysis

Psychological distress associated with active surveillance in patients younger than 70 with a small renal mass

Collaborators (2)

Thenappan Chandrasekar

Hanan Goldberg

Make your next move.